Freedom Biosciences is a clinical-stage biotechnology platform developing next-generation neuropsychiatric therapeutics. Through its discovery platform, Freedom Biosciences has identified the most efficacious combinations of chemicals to advance the safety and therapeutic profiles of existing therapeutics. With programs with clinical data and multiple exploratory programs, Freedom Biosciences has a diverse portfolio of assets that are positioned to significantly change the way we treat mental health indications.
Freedom Biosciences is co-founded by Dr. John Krystal and Dina Burkitbayeva. Dr. John Krystal is the Chair of the Department of Psychiatry at Yale University and Chief of Psychiatry and Behavioral Health at Yale-New Haven Hospital. Dina Burkitbayeva is a co-founder of PsyMed Ventures.
Company Details
- Employees
- 5
- Founded
- 2021
- Address
- Hunter R. Bouchard
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.freedombio.co
Freedom Biosciences Questions
Freedom Biosciences's website is http://www.freedombio.co
Freedom Biosciences's LinkedIn profile is https://www.linkedin.com/company/freedom-biosciences
Freedom Biosciences has
5 employees.
View email and phone details for 5
employees at Freedom Biosciences.
Freedom Biosciences's industry is
Biotechnology Research
Freedom Biosciences's top competitors are
Attune Neurosciences, Inc.,
Relmada Therapeutics, Inc,
Compass Pathways,
Atai Life Sciences,
Mindstate Design Labs,
Mindmed,
Xylo Bio,
Alto Neuroscience,
Psymed Ventures,
Vistagen.
Freedom Biosciences's categories are Biotechnology Research
Freedom Biosciences's founding year is 2021
